Source disclosure: February 06, 2026

KAKEN PHARMACEUTICAL CO.,LTD. [4521.T]

TOKYO, Feb 06 (Pulse News Wire) – KAKEN PHARMACEUTICAL CO.,LTD. (4521.T) released its earnings presentation for Q3 FY2026.

6 billion. 8% YoY).

17 billion. 4 billion (+92.7% YoY).

Note: Financial figures from the earnings presentation have been removed pending correction. For accurate figures, refer to the company's earnings summary (kessan tanshin) filed separately on TDNet.

AI-translated content. 🟢 Confidence: High See termsOriginal filing

💬 Help us improve translation quality
Notice any errors in this article? Let us know with one click.
🎁 Report 3+ errors with your email and get a free month of premium access